Angiotensin-converting enzyme inhibitors (ACEI) are effective and widely used antihypertensive agents, and many studies have proved their advantages with respect to quality of life (1). In particular, ACEI-induced sexual dysfunction is very rare (1).
Angiotensin-converting enzyme (ACE) is widely distributed, and its activity has been demonstrated in human gonadal tissues (2). Testicular ACE, an isozyme of pulmonary ACE, has a lower molecular weight and a different amino acid sequence (3). However, its roles are unclear. Few studies have evaluated the effects of ACEI on gonadal steroids (1). However, current evidence indicates that gonadal steroids play a role in the development of cardiovascular disease (4).
We studied the effects of lisinopril on plasma concentrations of gonadal hormones in men and women with essential hypertension.
Subjects and Methods
Twenty-one patients with essential hypertension, 10 men and 11 women aged 51 to 83 yr (men 66.4 ± 2.4 yr, women 64.8 ± 2.8, combined 65.6 ± 1.8; mean ± SEM) were enrolled. Their systolic blood pressures (SBP) were 160 mmHg or diastolic blood pressures (DBP) were '=95 mmHg (or both). Patients already receiving antihypertensive medications other than ACEI at entry who met the critefia for blood pressure were also eligible provided that their medications would not be changed during the study. Patients were excluded if they had secondary hypertension, renal failure, clinically important hepatic or cardiovascular diseases, diabetes mellitus, or other diseases with potential effects on plasma gonadal steroid concentrations.
This study was performed at 7 affiliated hospitals after the protocol had been approved by the institutional review committee of each institution. Informed consent was obtained from all patients before enrollment. Lisinopril was given once daily in a dose of 5 to 20 mg/d for 6 mo. The subjects were followed up at intervals of 2 to 4 wk.
The following variables were measured: SBP, DBP, pulse rate, and body weight (BW) were measured at each visit. At baseline and the 6-mo visit, blood samples were drawn from each patient after an overnight fast; blood count, serum biochemistry, total cholesterol (TC), HDL-cholesterol (HDL-C), triglyceride (TG), plasma total testosterone (T), free testosterone (f-T), estradiol (E2), and sex hormone binding globulin (SHBG) were measured. Plasma T, f-T, and E2 concentrations were measured with commercially available radioimmunoassay kits (Nippon DPC Corp., Tokyo, Japan), and SHBG concentrations were measured with an immunoradiometric assay kit (Farmos Diagnostica, Oulun-salo, Finland). The detection limits of T, f-T, E2, and SHBG were 0.04 ng/ml, 0.24 pg/ml, 10 pg/ml, and 0.5 nmol/1, respectively. The intraassay coefficient of variation for T, f-T, E2, and SHBG ranged from 4.8-6.5%, 3.8-6.1%, 3.7-7.5%, and 3.4-4.9%, respectively. The interassay coefficient of variation for T, f-T, E2, and SHBG ranged from 5.9-7.3%, 2.1-7.8%, 4.2-8.1%, and 2.0-8.3%, respectively. Paired samples were measured in the same assay. All assays were performed at Shionogi Biomedical Laboratory (Osaka, Japan).
Undetectable concentrations were assigned the value of the detection limit of the assay. All data are expressed as means ± SEM. Statistical analyses of differences were performed with the Wilcoxon rank sum test. p < 0.05 was considered to indicate statistical significance.
Results
Drug compliance was excellent. Only one woman dropped out of the study; the other 20 patients were observed for 6 mo. Two patients had minor adverse effects (transient leukopenia and mild anemia).
SBP, DBP, and mean blood pressures (MBP) decreased significantly after lisinopril administration. BW did not change significantly (Table 1) .
In men, lisinopril significantly reduced the f-T level (p < 0.05) (Fig. 1) , whereas T and SHBG levels were unaffected (Table 1, Fig. 2 ). Women had a nopril ma E2 significant increase in SHBG level administration (p < 0.01) (Fig. 2) . level did not change significantly after lisiThe plasin either men or women (Table 1) . TC decreased significantly in men and women combined (p < 0.05) and in men (p < 0.01). HDL-C and TG levels were not significantly altered by lisinopril (Table 1) .
Discussion
This study demonstrated that long-term lisinopril treatment significantly lowered the plasma f-T concentration in male hypertensive patients, possibly through its inhibition of ACE. The role of angiotensin II in gonadal steroidogenesis remains controversial. In vitro studies showed that angiotensin II stimulates estrogen production and inhibits T production (5, 6). In contrast, Morris et al. (7) reported that angiotensin blockade by saralasin enhanced E2 production, but did not change T production, consistent with the results of Palumbo et al. (8) , who found that stimulation of angiotensin II increased production of T and progesterone in human luteinized granulosa cells. Bumpus et al. (9) also reported that angiotensin II increased T secretion from ovarian slices. Since hypertensive men have lower androgen concentrations than normotensive men (10) , the change of blood pressure alone is an unlikely explanation for the lisinopril-induced decrease in f-T. Thus, the mechanism by which lisinopril decreases f-T levels remains to be defined.
Lisinopril increased the SHBG concentration significantly in female hypertensive patients and slightly but not significantly in male hypertensive patients. Several studies have shown that low-calorie diet and weight loss are related to an increase in SHBG (11) . The hypertensive patients enrolled in this study were not instructed to change their diet, and body weights did not change significantly after lisinopril administration. Gonadal hormones have established effects on the plasma SHBG concentration, estrogens producing an increase and androgens a decrease (11) . However, the increase in SHBG in our study was most likely not caused by gonadal hormones, because E2 did not change in either sex and T and f-T did not change in female hypertensives. The decrease in f-T might have increased the SHBG level insignificantly in male hypertensives. Another possibility is that lisinopril may have affected the metabolic clearance rate and production rate of SHBG.
The clinical implications of the decrease in f-T in male hypertensive patients remains to be clarified. The role of T in coronary heart disease is controversial. Most studies have shown no difference in T concentrations between survivors of a myocardial infarction and controls, whereas others have reported decreased T levels in patients with myocardial infarction (4). It is thus difficult to determine whether differences in T levels are the cause or the outcome.
Low SHBG levels represent a significant risk factor for 12-yr overall mortality in Swedish postmenopausal women (12) . In contrast, a negative relationship between the SHBG level and vertebral bone density has been reported (13) . The clinical implications of the increase in SHBG in female hypertensive patients given lisinopril in this study also remain to be determined.
Lisinopril significantly lowered TC levels in men and women combined and in men alone. One possible explanation is weight reduction. However, this possibility is unlikely, because the patients were not directed to change their life styles, BW did not change significantly, and there was no significant correlation between the BW change and TC change. Another possibility is that the change in f-T level might have affected the TC level. However, this assumption was also excluded because the correlation between f-T change and the TC change was insignificant. Although the mechanism of the decrease in TC remains to be clarified, another ACEI has been reported to decrease TC levels (14) .
In conclusion, our results suggest that lisinopril decreases plasma f-T levels in hypertensive men and increases SHBG in hypertensive women. However, confirmation of our findings by double-blind, placebo-controlled studies is necessary to arrive at firm conclusions. maru, T. Imamura, Z. Saitoh, K. Ueda, T. Matsubara, and Y. Hiraiwa for participating in the patient evaluation and follow-up. 
